| LN&Planting (N=53) |
Other (N=46) |
P-value | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 55.5 (9.75) | 54.6 (10.8) | 0.474 |
| Median [Min, Max] | 56.0 [24.0, 79.0] | 53.0 [28.0, 82.0] | |
| Operation_history | |||
| Direct_surgery | 29 (54.7%) | 37 (80.4%) | 0.00856 |
| Septal_tumor_reduction | 0 (0%) | 1 (2.2%) | |
| Surgery_after_neoadjuvant | 24 (45.3%) | 8 (17.4%) | |
| Type | |||
| CCC | 1 (1.9%) | 1 (2.2%) | 0.339 |
| EC | 1 (1.9%) | 2 (4.3%) | |
| HGSC | 48 (90.6%) | 41 (89.1%) | |
| LGSC | 2 (3.8%) | 0 (0%) | |
| MC | 0 (0%) | 2 (4.3%) | |
| Missing | 1 (1.9%) | 0 (0%) | |
| Clinical_stage | |||
| I | 0 (0%) | 1 (2.2%) | <0.001 |
| II | 0 (0%) | 8 (17.4%) | |
| III | 19 (35.8%) | 26 (56.5%) | |
| IV | 34 (64.2%) | 11 (23.9%) | |
| Planting_metastasis | |||
| No | 0 (0%) | 7 (15.2%) | 0.0107 |
| Yes | 53 (100%) | 39 (84.8%) | |
| Lymph.node_metastasis | |||
| No | 0 (0%) | 41 (89.1%) | <0.001 |
| Yes | 53 (100%) | 5 (10.9%) | |
| TMB_group | |||
| High | 3 (5.7%) | 2 (4.3%) | 1 |
| Low | 48 (90.6%) | 44 (95.7%) | |
| Missing | 2 (3.8%) | 0 (0%) | |
| Relapse_within_6months | |||
| Yes | 8 (15.1%) | 5 (10.9%) | 0.623 |
| No | 35 (66.0%) | 29 (63.0%) | |
| Unknown | 10 (18.9%) | 12 (26.1%) |